- Home
- HQ vs YDES Comparison
HQ vs YDES Comparison
Compare HQ & YDES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | HQ | YDES |
|---|---|---|
| Founded | 2018 | 2013 |
| Country | Singapore | Taiwan |
| Employees | 44 | N/A |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 623.1M | 543.0M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | HQ | YDES |
|---|---|---|
| Price | $12.45 | $2.53 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 301.3K | 34.7K |
| Earning Date | 05-05-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $8.29 | $1.70 |
| 52 Week High | $45.00 | $25.00 |
Technical Indicators
Market Signals| Indicator | HQ | YDES |
|---|---|---|
| Relative Strength Index (RSI) | 38.71 | 48.98 |
| Support Level | $9.79 | $1.93 |
| Resistance Level | $13.90 | $2.93 |
| Average True Range (ATR) | 2.07 | 0.32 |
| MACD | -0.00 | 0.04 |
| Stochastic Oscillator | 18.77 | 48.84 |
Price Performance
Historical ComparisonAbout HQ Horizon Quantum Holdings Ltd. Class A Ordinary Shares
Horizon Quantum Holdings Ltd is building software infrastructure to make quantum computers accessible to commercial enterprises and hardware providers. By bridging the gap between hardware and applications, the company seeks to equip developers, researchers, and enterprises with the quantum software infrastructure needed to solve real-world problems. The company is developing tools that can automatically accelerate code written for conventional computers on quantum computers.
About YDES YD Bio Limited Ordinary Shares
YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.